主要股东
注：以下部分股东代表特定权益共同体，直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Woodford Investment Management Ltd | 是 | 2984.39万 | 31.10% | 新增 | 新增 | -- |
| 2 | INVESCO Asset Management Limited | 是 | 1914.92万 | 19.90% | 新增 | 新增 | -- |
| 3 | Novartis Pharma AG | 是 | 1569.86万 | 16.00% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2024-09-12 | Fox Christine Ann |
|
10.84 | 4.47 | 是 | Chief Financial Officer |
| 2024-09-12 | Fox Christine Ann |
|
8.93 | 4.22 | 是 | Chief Financial Officer |
| 2024-09-12 | Hughes-Wilson Alexandra |
|
19.08 | 4.47 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-12 | Hughes-Wilson Alexandra |
|
15.08 | 4.47 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-12 | Hughes-Wilson Alexandra |
|
13.45 | 4.22 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-12 | Hughes-Wilson Alexandra |
|
5.05 | 4.22 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-12 | Lewicki John A. |
|
8.96 | 4.47 | 是 | Chief Scientific Officer |
| 2024-09-12 | Lewicki John A. |
|
7.86 | 4.22 | 是 | Chief Scientific Officer |
| 2024-09-12 | Scots-Knight Denise |
|
86.90 | 4.47 | 是 | Chief Executive Officer |
| 2024-09-12 | Scots-Knight Denise |
|
80.89 | 4.22 | 是 | Chief Executive Officer |
| 2024-09-12 | Sermon Charles |
|
24.00 | 4.47 | 是 | General Counsel |
| 2024-09-12 | Sermon Charles |
|
21.91 | 4.22 | 是 | General Counsel |
| 2024-09-11 | Sermon Charles |
|
25.00 | 0.00 | 是 | General Counsel |
| 2024-09-11 | Scots-Knight Denise |
|
89.76 | 0.00 | 是 | Chief Executive Officer |
| 2024-09-11 | Lewicki John A. |
|
9.48 | 0.00 | 是 | Chief Scientific Officer |
| 2024-09-11 | Fox Christine Ann |
|
11.76 | 0.00 | 是 | Chief Financial Officer |
| 2024-09-11 | Hughes-Wilson Alexandra |
|
7.45 | 0.00 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-11 | Hughes-Wilson Alexandra |
|
16.79 | 1.40 | 是 | Chief Patient Access and Commercial Planning |
| 2024-09-11 | Hughes-Wilson Alexandra |
|
24.29 | 1.01 | 是 | Chief Patient Access and Commercial Planning |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
0.18 | 3.00 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
0.83 | 1.84 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
2.07 | 2.72 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
5.97 | 1.31 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
10.32 | 0.94 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
10.52 | 3.87 | 是 | -- |
| 2024-08-22 | PAKIANATHAN DEEPIKA |
|
-- | 4.43 | 是 | -- |
| 2024-06-25 | Sermon Charles |
|
21.66 | 3.69 | 是 | General Counsel |
| 2024-06-25 | Sermon Charles |
|
18.44 | 3.39 | 是 | General Counsel |
| 2024-06-25 | Scots-Knight Denise |
|
80.18 | 3.69 | 是 | Chief Executive Officer |
| 2024-06-25 | Scots-Knight Denise |
|
70.95 | 3.39 | 是 | Chief Executive Officer |
| 2024-06-25 | Lewicki John A. |
|
6.56 | 3.69 | 是 | Chief Scientific Officer |
| 2024-06-25 | Lewicki John A. |
|
4.88 | 3.39 | 是 | Chief Scientific Officer |
| 2024-06-25 | Fox Christine Ann |
|
8.70 | 3.69 | 是 | Chief Financial Officer |
| 2024-06-25 | Fox Christine Ann |
|
5.76 | 3.39 | 是 | Chief Financial Officer |
| 2024-06-25 | Hughes-Wilson Alexandra |
|
5.75 | 3.69 | 是 | Chief Patient Access and Commercial Planning |
| 2024-06-25 | Hughes-Wilson Alexandra |
|
3.45 | 3.39 | 是 | Chief Patient Access and Commercial Planning |
| 2024-06-21 | Fox Christine Ann |
|
10.00 | 0.00 | 是 | Chief Financial Officer |
| 2024-06-21 | Sermon Charles |
|
23.08 | 0.00 | 是 | General Counsel |
| 2024-06-21 | Scots-Knight Denise |
|
84.25 | 0.00 | 是 | Chief Executive Officer |
| 2024-06-21 | Hughes-Wilson Alexandra |
|
6.77 | 0.00 | 是 | Chief Patient Access and Commercial Planning |
| 2024-06-21 | Lewicki John A. |
|
7.30 | 0.00 | 是 | Chief Scientific Officer |
| 2024-06-17 | WYZGA MICHAEL S |
|
2.51 | 3.99 | 是 | -- |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
10.10 | 1.40 | 是 | Chief Patient Access and Commercial Planning |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
5.86 | 2.99 | 是 | Chief Patient Access and Commercial Planning |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
0.77 | 1.40 | 是 | Chief Patient Access and Commercial Planning |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
8.27 | 1.01 | 是 | Chief Patient Access and Commercial Planning |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
3.26 | 2.94 | 是 | Chief Patient Access and Commercial Planning |
| 2024-05-22 | Hughes-Wilson Alexandra |
|
0.77 | 1.01 | 是 | Chief Patient Access and Commercial Planning |